Overview

The book presents the currently available clinical, epidemiological, and experimental data on short bowel syndrome (SBS), with special emphasis on the medical, surgical, and nutritional care of patients affected by SBS, based on the most up-to-date, evidence-based data available.

Prevalence and Causes

The prevalence of SBS has been rising along with significant advances in medicine and the overcoming of barriers such as more aggressive cancer resections and the increase in life expectancy, which has led to a higher prevalence of mesenteric ischemia and thrombosis. More recently, the SARS-CoV-2 infection has caused an increase in the incidence of thrombosis.

Emerging Treatments and Research

The rising prevalence of SBS has prompted researchers and healthcare professionals to explore innovative treatments such as intestinal transplantation and the development of specialized diets and medications to improve patients' quality of life. The volume emphasizes the use of growth factors, which are likely to become increasingly important for promoting the structural adaptability of the intestine. It also highlights the need for ongoing research in the field of SBS to further understand the underlying mechanisms and develop new treatment options.

Patient Care and Education

Additionally, it highlights the importance of patient education and empowerment in managing their condition and making informed decisions about their care. The importance of a skilled interdisciplinary team in providing care for these individuals is also outlined.

Target Audience

This book will serve as a quick reference on the medical, surgical, and nutritional care of complex patients with SBS, for nutritionists, dietitians, general practitioners, gastroenterologists, surgeons, nurses, and pharmacists alike.